Ortec Claiming OrCel Superiority Over Standard Burn Donor Site Treatments
This article was originally published in The Gray Sheet
Executive Summary
Ortec International plans to identify a sales partner to market its OrCel composite cultured skin for treating burn victims' autograft donor site wounds by the first quarter of 2002.
You may also be interested in...
Bioheart Pursues OrCel Cardiac Regeneration; Ortec Chases Ulcer Claims
Bioheart, Inc.'s Myocell may provide Ortec entry into the cardiovascular regeneration market, under a deal covering the cell transplantation product in combination with Ortec's OrCel collagen sponge and vascular endothelial growth factor technologies
Bioheart Pursues OrCel Cardiac Regeneration; Ortec Chases Ulcer Claims
Bioheart, Inc.'s Myocell may provide Ortec entry into the cardiovascular regeneration market, under a deal covering the cell transplantation product in combination with Ortec's OrCel collagen sponge and vascular endothelial growth factor technologies
Device Companies Work With Health Officials Tending Wounds Of The Nation
CDRH worked with skin replacement device firms to overcome logistical challenges in delivering medical supplies to those injured by terrorist attacks in Washington D.C. and New York City Sept. 11, agency and company officials indicate.